- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/64 - Oxygen atoms
Patent holdings for IPC class C07D 333/64
Total number of patents in this class: 94
10-year publication summary
|
7
|
8
|
8
|
9
|
7
|
7
|
8
|
5
|
6
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Board of Trustees of the University of Illinois | 2739 |
13 |
| Novartis AG | 10376 |
8 |
| BioCryst Pharmaceuticals, Inc. | 179 |
7 |
| Radius Pharmaceuticals, Inc. | 56 |
5 |
| Arcus Biosciences, Inc. | 154 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 855 |
4 |
| Merck Patent GmbH | 5716 |
3 |
| Genzyme Corporation | 1330 |
3 |
| Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 42 |
3 |
| Sutro Biopharma, Inc. | 177 |
3 |
| Board of Regents, The University of Texas System | 6018 |
2 |
| Antabio SAS | 23 |
2 |
| Cayman Chemical Company, Incorporated | 64 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 303 |
2 |
| Nikang Therapeutics, Inc. | 107 |
2 |
| Merck Sharp & Dohme Corp. | 2185 |
1 |
| Bayer Pharma AG | 1028 |
1 |
| FUJIFILM Corporation | 30206 |
1 |
| Takeda Pharmaceutical Company Limited | 2720 |
1 |
| Cadila Healthcare Limited | 301 |
1 |
| Other owners | 26 |